ERICA BELL: Open Payments
NPI 1538543384 · PALMDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 16 payments from 10 companies in 2025. Trend: 2023 $318 · 2024 $354 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $90 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Lilly USA, LLC | 2 | $41 |
| Alkermes, Inc. | 1 | $35 |
| SANOFI PASTEUR INC. | 1 | $28 |
| Philips North America LLC | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| GENZYME CORPORATION | 1 | $19 |
| Exact Sciences Corporation | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: Wegovy, MOUNJARO, VIVITROL, BEXSERO, VAXELIS, SHINGRIX, Vest Therapy Und, PREVNAR 20.
Industry payments across CA — which companies pay providers there.
